Thursday, August 27, 2026

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Must Read



In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.



Source link

- Advertisement -spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -spot_img
Latest News

Who What Wear Podcast: Sunna Yassin

Welcome to The Who What Wear Podcast. Think of it as your direct line to the designers, stylists,...
- Advertisement -spot_img

More Articles Like This

- Advertisement -spot_img